The New Marlett Christopher A Holding in Integrated Surgical Systems Inc
Marlett Christopher A filed with the SEC SC 13D/A form for Integrated Surgical Systems Inc. The form can be accessed here: 000114420416136981. As reported in Marlett Christopher A’s form, the filler as of late owns 16.37% or 3,757,146 shares of the -company.
Integrated Surgical Systems Inc stake is a new one for the and it was filed because of activity on November 4, 2016. We feel this shows Marlett Christopher A’s positive view for the stock.
Reasons Why Marlett Christopher A Bought – Integrated Surgical Systems Inc Stock
The securities were acquired for investment purposes. The ReportingPerson intends to review his investment in the Issuer on a continuing basis and will routinely monitor a wide variety of investmentconsiderations, including, without limitation, current and anticipated future trading prices for the Common Stock, the Issuer’sfinancial position, operations, assets, prospects, strategic direction and business and other developments affecting the Issuer.The Reporting Person may from time to time take such actions with respect to his investment in the Issuer as he deems appropriate,including, without limitation, (i) acquiring additional shares or disposing of some or all of his shares of Common Stock (or othersecurities of the Issuer); (ii) changing his current intentions with respect to any or all matters referred to in this Item 4;and/or (iii) engaging in hedging, derivative or similar transactions with respect to any securities of the Issuer. Any acquisitionor disposition of the Issuer’s securities may be made by means of open-market purchases or dispositions, privately negotiatedtransactions, direct acquisitions from or dispositions to the Issuer.
At the date of this Schedule 13D, except as set forth in thisSchedule 13D, the Reporting Person does not have any immediate plans or proposals which would result in:
(a)Theacquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;
(b)Anextraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;
(c)Asale or transfer of a material amount of assets of the Issuer or any of its subsidiaries;
(d)Anychange in control of the present board of directors or management of the Issuer, including any plans or proposals to change thenumber or term of directors or fill any existing vacancies on the board;
(e)Anymaterial change in the present capitalization or dividend policy of the Issuer;
(f)Anyother material change in the Issuer’s business or corporate structure;
(g)Changesin the Issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition ofcontrol of the Issuer by any person;
(h)Causinga class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quotedin an inter-dealer quotation system of a registered national securities association;
(i)Aclass of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of theSecurities Exchange Act of 1940; or
(j)Anyaction similar to any of those actions enumerated above.
Integrated Surgical Systems, Inc. is a shell company. The Company was formed to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures. The Company is no longer engaged in any business activities related to its former business. The Company’s operations are limited to completing a business combination or strategic alliance, when a suitable candidate is identified. The Company intends to identify a target business and effect a business combination with a target business.
SEC Form 13D is filed within 10 days, by anyone who acquires beneficial ownership of 5%+ of any public firm. Activist investors and practices such as: company breakups, hostile takeovers, and change of control events, are permitted for this form filers. A filer must promptly update its 13D filing in case of acquisition or disposition of 1% or more of the securities that are the subject of the filing.
The stock closed at $0.8 during the last session. It is down 400.00% since April 26, 2016 and is uptrending. It has outperformed by 394.74% the S&P500.
Integrated Surgical Systems, Inc. is a shell company. The company has a market cap of $6.78 million. The Firm was formed to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures. It currently has negative earnings. The Firm is no longer engaged in any business activities related to its former business.
More recent Integrated Surgical Systems, Inc. (OTCMKTS:ISSM) news were published by: Prnewswire.com which released: “Olympus Awarded an Innovative Technology Designation for Fourth Consecutive …” on November 28, 2016. Also Nasdaq.com published the news titled: “BK Ultrasound, Powered by Analogic, Introduces bkFusion at RSNA 2016” on November 27, 2016. Globenewswire.com‘s news article titled: “Vital and Stratasys to Exhibit the Innovative Role of 3D Printing and …” with publication date: November 26, 2016 was also an interesting one.
According to Zacks Investment Research, “Integrated Surgical Systems designs, manufactures, sells and services image-directed, computer controlled robotic products for use in orthopaedic and neurosurgical procedures.”
ISSM Company Profile
Integrated Surgical Systems, Inc., incorporated on October 1, 1990, is a shell company. The Firm was formed to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures. The Firm is no longer engaged in any business activities related to its former business.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.